Company / Free Cash Flow per Share
Jade Biosciences, Inc. Free Cash Flow per Share History
FY2021-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$2.16
FY2023
5-year range
-$2.24 / -$1.61
FY2021-FY2023
Trend
-34.5%
vs FY2022
Sector context
#137 of 191
Health Care
What the data says
At $-2.16, Jade Biosciences, Inc.'s free cash flow per share ranks #137 of 191 in the Health Care sector. Improved from $-2.24 to $-2.16 over the past 2 years.
Based on SEC 10-K filings.
-2.16 in FY2023.
Improved from $-2.24 to $-2.16 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#137 of 191 in Health CareTop 72% of 191This company -$2.16 Sector average -$24.68
▼
+91.2% above sector average
Key checks
Key Insights
- In FY2023, free cash flow per share decreased 34.5% year-over-year.
- Ranks #137 out of 191 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 6.03 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | -$2.16 | -34.5% |
| FY2022 | -$1.61 | +28.4% |
| FY2021 | -$2.24 | - |
| FY2020 | - | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026